Metoidioplasty and Phalloplasty Gender-Affirming Surgery and Association with Gender Congruence and Life Satisfaction: A Cross-Sectional Study
- PMID: 40151168
- PMCID: PMC11937767
- DOI: 10.1089/trgh.2023.0060
Metoidioplasty and Phalloplasty Gender-Affirming Surgery and Association with Gender Congruence and Life Satisfaction: A Cross-Sectional Study
Abstract
Purpose: The purpose of this study was to compare the Gender Congruence and Life Satisfaction (GCLS) Scale scores between transgender men and nonbinary individuals assigned female at birth who have had metoidioplasty and phalloplasty gender-affirming surgery (MaPGAS) versus those who have not.
Methods: We conducted a national cross-sectional survey of individuals considering or post-MaPGAS recruited through social media and a community health center. Data collected included demographics, medical health history, and GCLS scale scores. GCLS scale items evaluate gender congruence across psychological, physical, quality of life, genital, chest, and social domains on a 1-5 Likert scale, with higher values indicating greater gender congruence. The mean GCLS total and subscale scores were compared between groups, and open-ended comments related to gender, mental well-being, and life satisfaction were thematically analyzed.
Results: A total of 326 participants, mean age 29.9 years (standard deviation 8.8), identifying primarily as transgender male (n=208, 64%) and White (n=273, 74%) completed the survey. Respondents post-phalloplasty scored the highest on the GCLS scale overall, with a mean score of 3.97/5.00 (p<0.001), and had the highest ratings in three subdomains: genitalia at 3.32 (p<0.001), life satisfaction at 3.81 (p<0.004), and psychological functioning at 4.22 (p=0.002). Respondents who had not undergone MaPGAS had the lowest ratings of gender congruence on the genitalia subscale (mean score=2.82). The open-ended comments frequently cited the COVID-19 pandemic as an exacerbating issue with gender congruence.
Conclusion: In this cohort of individuals considering MaPGAS, individuals post-MaPGAS demonstrated higher GCLS scale scores. Individuals post-phalloplasty reported the highest overall GCLS score and majority subscale scores.
Keywords: bottom surgery; gender congruence and life satisfaction; gender-affirming surgery; metoidioplasty; phalloplasty; trans man.
Copyright 2025, Mary Ann Liebert, Inc., publishers.
Similar articles
-
New insights into the goals of transgender male versus non-binary individuals considering metoidioplasty and phalloplasty gender-affirming surgery.J Sex Med. 2025 Apr 8;22(3):526-535. doi: 10.1093/jsxmed/qdae193. J Sex Med. 2025. PMID: 39870596
-
Decision making in metoidioplasty and phalloplasty gender-affirming surgery: a mixed methods study.J Sex Med. 2023 Jun 28;20(7):1032-1043. doi: 10.1093/jsxmed/qdad063. J Sex Med. 2023. PMID: 37173118 Free PMC article.
-
Exploring Decisional Conflict Experienced by Individuals Considering Metoidioplasty and Phalloplasty Gender-affirming Surgery.Plast Reconstr Surg Glob Open. 2024 May 30;12(5):e5840. doi: 10.1097/GOX.0000000000005840. eCollection 2024 May. Plast Reconstr Surg Glob Open. 2024. PMID: 38818233 Free PMC article.
-
Outcomes Following Gender Affirming Phalloplasty: A Systematic Review and Meta-Analysis.Sex Med Rev. 2022 Oct;10(4):499-512. doi: 10.1016/j.sxmr.2022.03.002. Epub 2022 Aug 26. Sex Med Rev. 2022. PMID: 36031521
-
Surgical versus non-surgical interventions for treating patellar dislocation.Cochrane Database Syst Rev. 2023 Jan 24;1(1):CD008106. doi: 10.1002/14651858.CD008106.pub4. Cochrane Database Syst Rev. 2023. PMID: 36692346 Free PMC article.
References
-
- American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. American Psychiatric Association Publishing: Washington, DC, USA; 2022; pp. 511–520.
-
- Frey JD, Poudrier G, Chiodo MV, et al. . A systematic review of metoidioplasty and radial forearm flap phalloplasty in female-to-male transgender genital reconstruction: Is the “ideal” neophallus an achievable goal? Plast Reconstr Surg Glob Open 2016;4(12):e1131; doi: 10.1097/GOX.0000000000001131 - DOI - PMC - PubMed